July 15, 2020
Pfizer could have COVID-19 vaccine by October
Editor's Note
Food & Drug Administration (FDA) approval of Pfizer’s COVID-19 vaccine could happen in October, the July 12 Time reports. The company was granted FDA Fast Track designation for the vaccine.
Pfizer’s vaccine, being developed with its German biotech partner BioNTech, uses a messenger-RNA, genetics-based approach.
Pfizer CEO Albert Bourla says they should have enough data by September on the success of the vaccine to submit to the FDA. The company plans to begin manufacturing the vaccine ahead of FDA approval.
Free Daily News
- ACS conference charts bold future for surgical quality with data, teamwork, frontline innovation
- Surgical leaders urged to weigh risks, rewards of innovation with a critical eye
- Health systems report dramatic nurse retention gains through residency, development programs
- Surgical innovation redefines what is possible for advanced colorectal cancer
- CMS proposal to end inpatient only list draws strong industry response
- Fall deaths among older adults have tripled, prescription drugs under scrutiny
- AI could shrink drug discovery from years to months, expert says
- AI vendors bet on guaranteed ROI as competition with Epic intensifies
- AMA 2026 CPT code set expands with AI, remote monitoring, leg revascularization updates
- PACU initiative cuts emergency response times from 9 to 2 minutes
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement